GlassScriptPhysician profile
Sarah S Smith
NPI 1750643706
$6,332.28
in general payments reported to CMS, 2019-2025
44 companies · $2,463 in 2025
The $2,463 reported for 2025 was more than what 95% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $1,126 · 2023: $1,191 · 2024: $1,211 · 2025: $2,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,864.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,848.58 | 2022-2025 | |
| Argenx US, INC. | $525.79 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $412.74 | 2024-2025 | Vyepti, Rexulti |
| Novo Nordisk INC | $388.38 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Jazz Pharmaceuticals INC. | $386.46 | 2021-2024 | |
| Upsher-Smith Laboratories LLC | $258.94 | 2021-2023 | |
| Tg Therapeutics, INC. | $225.59 | 2023-2025 | |
| Csl Behring | $177.32 | 2021-2025 | Hizentra, Kcentra |
| Neurelis, INC. | $170.38 | 2024-2025 | Valtoco |
| Sk Life Science, INC. | $169.84 | 2021-2024 | |
| Merz North America, INC. | $144.57 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $143.84 | 2024-2025 | Wainua |
| Pfizer INC. | $119.44 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $116.44 | 2023 | Aptiom |
| Livanova USA, INC. | $104.02 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.